Evidence map›Paper›PMID 34443458›Full record

ArticleMolecules (Basel, Switzerland)2021

Phenolics Profiling of

Saheed Sabiu, Fatai O Balogun, Stephen O Amoo

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Profiling and cheminformatics bioprospection of curcurbitacin I and momordin Ic fromJournal of enzyme inhibition and medicinal chemistry · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mechanistic Exploration ofBioMed research international · 2025
    Article
  8. Bioprospection ofInternational journal of medical sciences · 2025
    Article
  9. Hypoglycemic and hypolipidemic effects ofFood science & nutrition · 2024
    Article
  10. Exploring the therapeutic mechanism of potential phytocompounds fromSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Identification of New Drug Target inBioengineering (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Saheed SabiuDepartment of Biotechnology and Food Science, Durban University of Technology, P.O. Box 1334, Durban 4000, South Africa.ORCID 0000-0001-7209-9220
Fatai O BalogunDepartment of Biotechnology and Food Science, Durban University of Technology, P.O. Box 1334, Durban 4000, South Africa.ORCID 0000-0002-1125-0107
Stephen O AmooAgricultural Research Council-Vegetables, Industrial and Medicinal Plants, Pretoria, Private Bag X293, Pretoria 0001, South Africa.ORCID 0000-0003-0009-5436
Durban University of Technology · ZAUniversity of Johannesburg · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adverse effects associated with synthetic drugs in diabetes therapy has prompted the search for novel natural lead compounds with little or no side effects. Effects of phenolic compounds from

Indexed as

Molecular Dynamics SimulationAizoaceaeAnimalsChromatography, High Pressure LiquidDiabetes Mellitus, Type 2Diabetic RetinopathyEnzymesHypoglycemic AgentsMolecular Docking SimulationPhenolsRatsSwineThermodynamicsEnzymesHypoglycemic AgentsPhenolsaldose reductasealpha-amylasealpha-glucosidaseenzyme inhibitorsmolecular dynamics simulationphenolics

Identifiers

PMID34443458
PMCPMC8401050
OpenAlexW3192461133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.